Senolytic therapies have the potential to reverse diseases of aging.
Unity Biotechnology CEO Anirvan Ghosh Ph.D.
At this stage, senolytic therapies have the same revolutionary potential as checkpoint blockers, but they are more effective. This method delays the onset diseases of aging. It does this by removing the senescent cell from the body.
Senolytics, a relatively new field, is still largely being researched in academic institutions – notably the Mayo Clinic. It could be years, or even a decade before any therapeutics are approved.
Source:
https://www.biospace.com/article/senolytic-therapies-pose-revolutionary-potential-to-roll-back-diseases-of-aging/
